Nuwellis, Inc.

NUWE

Healthcare Medical Devices

Nuwellis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.3 million, down 5.38% from fiscal 2024.

Revenue
+14.1%
EPS
+98.8%
Free cash flow
−51.6%

Quarter to June 2026, against a year earlier

4.58 0.08 −1.72%
Market cap
$2.5M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
3/9
ROIC
0.00%
Net debt / EBITDA
0.1×
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
4 4 5 4 5 6 2 5 6 3
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
9,819,696,209.25 103,927,553.22 85,588,590.18 1,951,010.89 7,947,078.16 51,092.75 11,087.78 0.00 0.17 0.15
Altman Z-Score
1,718,305,953.32 97,126,445.15 90,374,281.47 1,785,986.11 9,604,888.78 54,310.39 42,065.39 (44.70) (44.17) (76.39)
Altman Z″-Score (non-manufacturers)
(88.11) (24.31) (80.96) (146.91) (34.19) (19.97) (34.15) (104.20) (99.99) (177.65)
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
— (1.13) 0.28 (1.61) (2.27) (2.15) (1.80) (2.96) (3.46) (7.71)
P/Operating CF
(5,487,371,461.75) (117,186,479.41) (157,442,684.47) (2,667,995.29) (17,346,497.08) (97,402.09) (30,291.94) 0.00 (0.98) (0.40)
P/B ratio
8,523,071,553.27 22,740,152.52 72,063,978.05 5,403,025.63 3,623,863.74 15,597.40 7,665.53 0.00 0.23 0.46
EV/Sales
9,819,696,212.25 103,927,550.50 85,588,590.26 1,951,011.42 7,947,076.75 51,090.20 11,086.10 0.02 0.04 0.49
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(912,611,172.14) (30,301,541.68) (28,985,755.12) (637,837.33) (3,511,740.49) (22,405.35) (6,201.86) (0.01) (0.03) (0.37)
Current Ratio
0.74 8.54 2.86 1.20 5.17 8.51 4.86 2.59 3.46 1.71
Net Debt/EBITDA
0.09 1.55 0.33 0.06 0.86 1.27 1.09 0.22 0.48 0.10
Debt/Equity
0.00 0.00 0.00 0.13 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(254.05%) (277.54%) (153.62%) (570.86%) (192.19%) (92.53%) (75.84%) (294.87%) (223.24%) (382.80%)
ROA
(110.85%) (192.64%) (125.09%) (314.69%) (137.37%) (77.55%) (52.73%) (131.39%) (108.22%) (219.21%)
ROIC
(1,065.15%) (1,439.74%) (2,334.98%) (1,164.22%) (550.00%) (689.48%) 0.00% 0.00% (478.57%) (449.27%)
Return on Tangible Assets
5,877.74% (152.80%) (292.50%) (1,349.82%) (108.93%) (75.19%) (76.20%) (392.49%) (156.83%) (694.57%)
Average Days of Receivables
79.85 55.99 57.40 52.92 44.39 34.56 60.07 80.34 72.12 65.89
Earnings Yield
(0.22%) (13.00%) (94.44%) (883.50%) (175.35%) (35.91%) (47.20%) (123.79%) (385.39%) (5,144.23%)
Free Cash Flow Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (0.02%) 0.00% (658.11%) (906.97%)
Free Cash Flow per Share
(497.24) (253.73) (36.53) (208.11) (10.21) (261.77) (87.76) (476,296.49) (96,510.00) (4,954.55)
Book value per Share
67.94 338.29 14.69 24.57 9.90 376.04 71.02 84,101.62 65,300.00 1,195.45
Free Cash Flow
(16.41) (12.18) (14.76) (16.86) (16.84) (18.06) (15.27) (18.18) (9.65) (10.90)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026